North America Anaphylaxis Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Anaphylaxis Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Anaphylaxis Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Anaphylaxis Treatment Market Regional Analysis

6.2 North America Anaphylaxis Treatment Market Revenue 2019-2028 (US$ Million)

6.3 North America Anaphylaxis Treatment Market Forecast Analysis

7. North America Anaphylaxis Treatment Market Analysis – by Medication Type

7.1 Epinephrine

7.1.1 Overview
7.1.2 Epinephrine: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Antihistamines

7.2.1 Overview
7.2.2 Antihistamines: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Steroids

7.3.1 Overview
7.3.2 Steroids: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Beta-Agonist

7.4.1 Overview
7.4.2 Beta-Agonist: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Anaphylaxis Treatment Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Parenteral

8.2.1 Overview
8.2.2 Parenteral: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Anaphylaxis Treatment Market Analysis – by Allergy Type

9.1 Food Allergy

9.1.1 Overview
9.1.2 Food Allergy: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Medications

9.2.1 Overview
9.2.2 Medications: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Insect Stings

9.3.1 Overview
9.3.2 Insect Stings: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Anaphylaxis Treatment Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Retail Sales

10.2.1 Overview
10.2.2 Retail Sales: North America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America Anaphylaxis Treatment Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Anaphylaxis Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America Anaphylaxis Treatment Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Anaphylaxis Treatment Market Breakdown, by Medication Type
11.2.1.1.2 US: North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
11.2.1.1.3 US: North America Anaphylaxis Treatment Market Breakdown, by Allergy Type
11.2.1.1.4 US: North America Anaphylaxis Treatment Market Breakdown, by Distribution Channel

11.2.1.2 Canada: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Anaphylaxis Treatment Market Breakdown, by Medication Type
11.2.1.2.2 Canada: North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
11.2.1.2.3 Canada: North America Anaphylaxis Treatment Market Breakdown, by Allergy Type
11.2.1.2.4 Canada: North America Anaphylaxis Treatment Market Breakdown, by Distribution Channel

11.2.1.3 Mexico : North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Medication Type
11.2.1.3.2 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
11.2.1.3.3 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Allergy Type
11.2.1.3.4 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Amneal Pharmaceuticals Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Mylan N.V.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Adamis Pharmaceutical Corporation

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Abbott

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Pfizer Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Glaxosmithkline Plc.,

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Merck And Co., Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Teva Pharmaceutical Industries Ltd.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 ALK-ABELLó

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Anaphylaxis Treatment Market

Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)